Newswise — Los Angeles (October 20, 2022) —
Physician Scientist in the Department of Radiation Oncology Cedars – Sinai Cancer Present research and discuss advances in clinical care at American Society for Radiation Oncology (ASTRO) Annual Meeting San Antonio, October 23-26.
Howard Sandler, MDchair of Department of Radiation Oncology The Ronald H. Bloom Family Chair of Cancer Therapeutics at Cedars-Sinai was recently appointed. ASTRO President-Elect and can be interviewed. Sandler is a nationally recognized radiation oncologist and expert in genitourinary cancer.
At the conference, Sandler will provide an expert commentary on the results of a randomized phase II trial of metastasis-directed therapy added to intermittent hormone therapy for oligometastatic prostate cancer. during a media briefing. He also oversees mentorship networking activities for first-time conference attendees and medical students.
He will also attend several other sessions, including the presentation of a paper co-authored by his colleague Stephen Friedland, MD. Challenges and Solutions During the COVID Pandemic for Patient Retention and Physician Involvement in the Phase 3 ATLAS Trial of Apalutamide Added to Androgen Deprivation Therapy in High-Risk Localized or Locally Advanced Prostate Cancer.
It can also be presented at conferences and used for interviews.
Kaitlyn Atkins, MD, PhDMedical Director of Radiation Oncology and Assistant Professor of Radiation Oncology at Cedars-Sinai will speak. Optimization of thoracic radiotherapy planning and reduction of treatment toxicity We discuss her research on abnormal heart rhythms and radiotherapy for lung cancer.
Leslie Barras, M.D.a radiation oncologist presents Treatment Considerations for High-Risk Patients with PSMA Stage We discuss prostate cancer and prostate-specific membrane antigen (PSMA) PET imaging.She also presents a study titled What is Lymphoma?: DLBCL, VMTBI, NKTCL, RTCART He will speak on the “real world” use of radiation therapy in multiple myeloma, on bladder cancer with limited spread, and will moderate a panel on bladder and kidney preservation.
Stephen Friedland, MDDirector of the Center for Integrative Research in Cancer and Lifestyle and author of the Warschaw Robertson Law Families Chair in Prostate Cancer at Cedars-Sinai. Results of the 17-Gene Genomic Prostate Score Assay After External Beam Therapy and Association with Long-Term Outcomes in Patients with Intermediate- or High-Risk Prostate Cancer, Regardless of Ethnicity Look at biomarkers for prostate cancer outcomes. he is available for an interview.
Mitchell Kamraba, M.D.Director of Brachytherapy Services and Associate Professor of Radiation Oncology, will join a panel discussion on personalized care and emerging advances in gynecologic cancers.
Cedars-Sinai can accommodate many virtual interview formats including Zoom, FaceTime and Skype.
The American Society for Radiation Oncology (ASTRO) Annual Meeting will be held virtually October 23-26 in San Antonio.